[(2S,3R,4R,5R,6R)-5-[(2S,3R,4S,5R)-5-(1,2-dihydroxyethyl)-4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6bR,12aR,14bR)-10-[(2S,3R,4R,5R)-5-[(2S,3S,4R,5S,6S)-3-[(2S,3R,4S,5R)-3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-14b-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,13-dodecahydro-1H-picene-4a-carboxylate

Details

Top
Internal ID 49c2d393-4e4c-40ea-a22d-b2b941cc596a
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name [(2S,3R,4R,5R,6R)-5-[(2S,3R,4S,5R)-5-(1,2-dihydroxyethyl)-4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6bR,12aR,14bR)-10-[(2S,3R,4R,5R)-5-[(2S,3S,4R,5S,6S)-3-[(2S,3R,4S,5R)-3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-14b-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,13-dodecahydro-1H-picene-4a-carboxylate
SMILES (Canonical) CC1C(C(C(C(O1)OC2COC(C(C2O)O)OC3CCC4(C(C3(C)C)CCC5(C4CC=C6C5(CCC7(C6(CC(CC7)(C)C)O)C(=O)OC8C(C(C(C(O8)CO)OC9C(C(C(O9)C(CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)C)C)C)OC1C(C(C(CO1)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2O)O)OC3CC[C@]4(C(C3(C)C)CC[C@@]5(C4CC=C6C5(CC[C@@]7([C@]6(CC(CC7)(C)C)O)C(=O)O[C@H]8[C@@H]([C@H]([C@H]([C@H](O8)CO)O[C@H]9[C@@H]([C@H]([C@H](O9)C(CO)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)O)C)C)C)O[C@H]1[C@@H]([C@H]([C@@H](CO1)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)O)O
InChI InChI=1S/C70H114O36/c1-26-37(77)43(83)54(104-57-50(90)52(28(76)23-93-57)101-58-46(86)41(81)38(78)29(20-72)96-58)61(95-26)99-32-24-94-56(45(85)40(32)80)100-36-12-13-66(6)33(65(36,4)5)11-14-67(7)34(66)9-10-35-68(67,8)16-18-69(17-15-64(2,3)25-70(35,69)92)63(91)106-60-48(88)44(84)53(31(22-74)98-60)103-62-55(49(89)51(102-62)27(75)19-71)105-59-47(87)42(82)39(79)30(21-73)97-59/h10,26-34,36-62,71-90,92H,9,11-25H2,1-8H3/t26-,27?,28+,29+,30+,31+,32+,33?,34?,36?,37+,38+,39+,40-,41-,42-,43+,44+,45+,46+,47+,48+,49-,50+,51+,52-,53-,54-,55+,56-,57-,58-,59-,60-,61-,62-,66-,67+,68?,69+,70+/m0/s1
InChI Key VTFYIOPXPFTCQF-JGDKNQBSSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C70H114O36
Molecular Weight 1531.60 g/mol
Exact Mass 1530.7089799 g/mol
Topological Polar Surface Area (TPSA) 571.00 Ų
XlogP -4.50
Atomic LogP (AlogP) -7.14
H-Bond Acceptor 36
H-Bond Donor 21
Rotatable Bonds 19

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3R,4R,5R,6R)-5-[(2S,3R,4S,5R)-5-(1,2-dihydroxyethyl)-4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6bR,12aR,14bR)-10-[(2S,3R,4R,5R)-5-[(2S,3S,4R,5S,6S)-3-[(2S,3R,4S,5R)-3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-14b-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,13-dodecahydro-1H-picene-4a-carboxylate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8593 85.93%
Caco-2 - 0.8653 86.53%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.7857 78.57%
Subcellular localzation Mitochondria 0.8538 85.38%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.7550 75.50%
OATP1B3 inhibitior - 0.2138 21.38%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.6250 62.50%
BSEP inhibitior + 0.9091 90.91%
P-glycoprotein inhibitior + 0.7434 74.34%
P-glycoprotein substrate + 0.6633 66.33%
CYP3A4 substrate + 0.7550 75.50%
CYP2C9 substrate - 0.7973 79.73%
CYP2D6 substrate - 0.8649 86.49%
CYP3A4 inhibition - 0.9081 90.81%
CYP2C9 inhibition - 0.8652 86.52%
CYP2C19 inhibition - 0.9198 91.98%
CYP2D6 inhibition - 0.9299 92.99%
CYP1A2 inhibition - 0.9086 90.86%
CYP2C8 inhibition + 0.7887 78.87%
CYP inhibitory promiscuity - 0.9357 93.57%
UGT catelyzed + 1.0000 100.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.5124 51.24%
Eye corrosion - 0.9896 98.96%
Eye irritation - 0.8972 89.72%
Skin irritation - 0.5174 51.74%
Skin corrosion - 0.9392 93.92%
Ames mutagenesis - 0.6770 67.70%
Human Ether-a-go-go-Related Gene inhibition + 0.7848 78.48%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.8750 87.50%
skin sensitisation - 0.9021 90.21%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity + 0.9444 94.44%
Mitochondrial toxicity - 0.5750 57.50%
Nephrotoxicity - 0.9856 98.56%
Acute Oral Toxicity (c) III 0.6216 62.16%
Estrogen receptor binding + 0.7359 73.59%
Androgen receptor binding + 0.7640 76.40%
Thyroid receptor binding + 0.6739 67.39%
Glucocorticoid receptor binding + 0.7927 79.27%
Aromatase binding + 0.6806 68.06%
PPAR gamma + 0.8102 81.02%
Honey bee toxicity - 0.6005 60.05%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity - 0.5200 52.00%
Fish aquatic toxicity + 0.9565 95.65%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.00% 91.11%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 97.49% 95.17%
CHEMBL2581 P07339 Cathepsin D 97.48% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.43% 96.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.98% 89.00%
CHEMBL221 P23219 Cyclooxygenase-1 92.52% 90.17%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 92.36% 91.24%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 91.46% 94.45%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.66% 86.33%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 88.69% 95.89%
CHEMBL3714130 P46095 G-protein coupled receptor 6 88.23% 97.36%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.14% 97.09%
CHEMBL218 P21554 Cannabinoid CB1 receptor 87.14% 96.61%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.92% 100.00%
CHEMBL2563 Q9UQL6 Histone deacetylase 5 84.83% 89.67%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 84.48% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.14% 95.89%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 84.10% 92.88%
CHEMBL5103 Q969S8 Histone deacetylase 10 83.09% 90.08%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 83.09% 97.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 82.81% 95.56%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 82.19% 93.04%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 82.15% 95.50%
CHEMBL5028 O14672 ADAM10 81.97% 97.50%
CHEMBL340 P08684 Cytochrome P450 3A4 81.76% 91.19%
CHEMBL5255 O00206 Toll-like receptor 4 81.48% 92.50%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 81.06% 91.07%
CHEMBL253 P34972 Cannabinoid CB2 receptor 80.93% 97.25%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 80.19% 94.00%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Patrinia scabiosifolia

Cross-Links

Top
PubChem 11968827
NPASS NPC104272